All News about Sesen Bio IncVia Benzinga
Sesen Bio Announces Anticipated Regulatory Path Forward for Vicineum™
December 09, 2021
From Sesen Bio, Inc.
Via Business Wire
From Sesen Bio
Via Business Wire
Sesen Bio, Inc. (NASDAQ:SESN) Long Term Investor Alert: Investigation of Potential Wrongdoing
November 18, 2021
Via SBWire
Topics
Lawsuit
From Sesen Bio
Via Business Wire
Sesen Bio Announces Productive CMC Type A Meeting with the FDA
November 01, 2021
From Sesen Bio
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|